Cannabis Stock News: Earth Alive (CSE: $EAC)
Announces Commercial Launch of Dr. Marijane Biofertilizer for Cannabis
Production
MONTREAL, QUEBEC - April 12, 2017 (Investorideas.com Newswire)
Earth Alive Clean Technologies Inc. (CSE:EAC)(CSE:EAC.CN) ("Earth
Alive" or the "Company"), a leading Canadian Clean-Tech company,
developer and manufacturer of state-of-the-art microbial technology-based
products for sustainable agriculture and mining, announces the commercial sales
launch of Dr. Marijane, the Company's specially formulated cannabis
biofertilizer.
Dr. Marijane is a 100% organic root probiotic that has been
shown to increase cannabis yields by up to 28%. Scientific testing and
validation of its performance began in 2014, and results have been repeatedly
confirmed by several licensed commercial producers over the last year. Starting
today, Dr. Marijane is available for purchase by growers in Canada and certain
regions of the United States.
"Cannabis is moving out of the basement and into the
boardroom, and with that move has come increased public scrutiny. In the face
of recent product recalls, it has become crucial for licensed producers to
cultivate healthy plants without adding more synthetic and potentially toxic
chemicals," stated David Gilmour, CEO of Earth Alive. "Dr. Marijane
meets the challenge by boosting marijuana yields and producing vigorous plants
in a safe and sustainable way."
Michael K. Warren, VP Global Operations, Agricultural Solutions,
noted, "There are more than 20,000 Canadians licensed to grow cannabis for
personal use under the current medical marijuana rules. Meanwhile, with the
Canadian government planning to legalize recreational marijuana by July 2018,
licensed growers are undertaking aggressive plans to expand their production
capacity. We are also offering the product in a number of states where
production is legal for recreational and medicinal purposes" He concluded,
"Dr. Marijane is a specialized biofertilizer designed to bring success to
cannabis growers, and we look forward to taking a place in this dynamic and
expanding sector."
Dr. Marijane is approved for organic production, does not
contain genetically modified ingredients or synthetic chemicals and can be used
with soil or soilless substrate. It is available in a range of packaging
formats suitable for retail and commercial production. For more information and
to order, please visit www.doctormarijane.com.
About
Earth Alive Clean Technologies:
Earth Alive aims to be a key player in world markets of
environmentally sustainable industrial solutions. The company works with the
latest innovations in microbial technology to formulate and patent innovative
products that can tackle the most difficult industrial challenges, once only
reserved to environmentally harmful chemicals and additives. The Company is
focused on environmental sustainability in the agriculture industry, and 2)
dust control for the mining industry.
For additional company information, please visit: www.earthalivect.com
The CSE has neither approved nor disapproved the contents of
this press release. The CSE does not accept responsibility for the adequacy or
accuracy of this release.
Forward-Looking Information
Except for statements of historical fact, this news release
contains certain forward-looking statements within the meaning of applicable
securities law. Forward-looking statements are frequently characterized by
words such as "plan", "expect", "project",
"intend", "believe", "anticipate",
"estimate" and other similar words, or statements that certain events
or conditions "may" occur. Although Earth Alive believes that the
expectations reflected in the forward-looking statements are reasonable, there
can be no assurance that such expectations will prove to be correct. Such
forward-looking statements are subject to risks and uncertainties that may
cause actual results, performance or developments to differ materially from
those contained in the statements. Except as required under applicable
securities legislation, the Company undertakes no obligation to publicly update
or revise forward-looking information, whether as a result of new information,
future events or otherwise.
For
media information and interview requests:
Mr. David Gilmour
514-814-2899
dgilmour@earthalivect.com
www.earthalivect.com
514-814-2899
dgilmour@earthalivect.com
www.earthalivect.com
For
investor relations:
Mr. Frederick Chabot
438-863-7071
frederick@contactfinancial.com
438-863-7071
frederick@contactfinancial.com
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment